NEW YORK, Sept. 16 - The Whitehead Institute Center for Genome Research will use Affymetrix GeneChips in studies designed to standardize the collection and analysis of tumor-biopsy data, Affy said today.
Working with an undisclosed number of "clinical institutions," the Whitehead will "study sample collection from tissue biopsies, amplification, data collection, and analysis. ...," according to Affy.
The center believes that "standardization will ensure" that expression data will be "comparable" by scientists who currently use DNA chips in their cancer research.
It was not immediately clear when the study will begin, but Affy said data from the research will eventually be published.
Click here for more information.